Search Results

You searched for : LatestBristolMyersSquibbNews  

	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
	European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo ... Jan 05
	European Medicines Agency Validates Bristol Myers Squibb’s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for the treatment of ulcerative colitis.... Dec 28
	Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme ... Dec 23
	Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
	Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR AML-001 Study of Onureg Results demonstrated treatment with Onureg improved overall survival, compared to placebo, in patients with AML in first remission.... Dec 08
	Bristol Myers Squibb Receives European Commission Approval for Opdivo Bristol Myers Squibb announced the approval of Opdivo for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma ... Nov 25
	Decreases in Americans' Primary Care Visits May Lead to Late Diagnoses of Potentially Serious Conditions The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organizations and medical societies, announces the launch of the No Time to Wait ... Oct 26
	USFDA Accepts for Priority Review Applications for OPDIVO in Combination with CABOMETYX in Advanced Renal Cell Carcinoma Results from CheckMate -9ER recently presented during a Presidential Symposium at the European Society for Medical Oncology Virtual Congress... Oct 19
10 Matching result(s) found!

Trending Now
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
	Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
	100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
	Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
	Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
	High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
	Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
	SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
	Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
	Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
	THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
	Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
	Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
	Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
	Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
	Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
	TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
	AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
	Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026